Sector
PharmaceuticalsOpen
₹180.85Prev. Close
₹172.95Turnover(Lac.)
₹0.3Day's High
₹180.85Day's Low
₹169.0552 Week's High
₹269.7552 Week's Low
₹105Book Value
₹34.73Face Value
₹10Mkt Cap (₹ Cr.)
111.29P/E
38.34EPS
4.51Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 6.44 | 6.44 | 6.44 | 6.44 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.02 | 11.28 | 9.16 | 6.73 |
Net Worth | 19.46 | 17.72 | 15.6 | 13.17 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 24.87 | 13.59 | 12.8 | 10.83 |
yoy growth (%) | 83.06 | 6.11 | 18.16 | -32 |
Raw materials | -9.91 | -4.85 | -4.8 | -3.94 |
As % of sales | 39.84 | 35.72 | 37.54 | 36.38 |
Employee costs | -2.53 | -2.41 | -2.25 | -2 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 4.04 | 1.84 | 1.05 | 0.83 |
Depreciation | -0.36 | -0.33 | -0.33 | -0.34 |
Tax paid | -0.65 | -0.2 | -0.02 | -0.03 |
Working capital | 1.48 | 2.04 | -0.55 | 0.24 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 83.06 | 6.11 | 18.16 | -32 |
Op profit growth | 79.81 | 49.87 | 12.03 | -23.81 |
EBIT growth | 106.34 | 65.14 | 16.47 | -28.8 |
Net profit growth | 105.76 | 59.76 | 28.15 | -42.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
NARAYANAN NARASIMHAN
Managing Director
Arvind Varchaswi N
Whole Time Director
Tejagna Kashmira Katpitia
Independent Director
CHANDRAKANT LAXMINARAYAN RATHI
Company Sec. & Compli. Officer
Yash Jain
Independent Director
Puvan Sripathy
Independent Director
Commodore H G Harsha
Independent Director
Prasana Prabhu
Independent Director
Romila Sen
Non Executive Director
Sturle Harald Pedersen
Non Executive Director
Jeewan Prakash Gupta
201 2nd Floor Sumeru Towers,
54/46 39 Jayanagar 4th Block,
Karnataka - 560041
Tel: 91-80-26087733
Website: http://www.source-natural.com
Email: investor_relations@source-natural.com; info@source
12-10-167,
Bharath Nagar,
Hyderbad - 500018
Tel: 91-040-23818475/76/2
Website: www.vccilindia.com
Email: info@vccilindia.com
Summary
Source Natural Foods &Herbal Supplements Limited was formerly incorporated as Inwinex Pharmaceuticals Limited in 1995. The Company name was then changed from Inwinex Pharmaceuticals Limited to Source ...
Read More
Reports by Source Natural Foods & Herbal Supplements Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.